{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:29:01Z","timestamp":1790378941423,"version":"4.1.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["847770"],"award-info":[{"award-number":["847770"]}]},{"name":"LOOP Study"},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["12-1352259"],"award-info":[{"award-number":["12-1352259"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation for the Capital Region of Denmark"},{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","award":["11-04-R83-A3363-22625"],"award-info":[{"award-number":["11-04-R83-A3363-22625"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aalborg University Talent Management Program"},{"DOI":"10.13039\/100007460","name":"Arvid Nilssons Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008276","name":"Skibsreder Per Henriksen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008276","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R og Hustrus Fond"},{"name":"European Union\u2019s Horizon 2020 program","award":["847770"],"award-info":[{"award-number":["847770"]}]},{"DOI":"10.13039\/501100008269","name":"L\u00e6ge Sophus Carl Emil Friis og hustru Olga Doris Friis\u2019 Legat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["648131"],"award-info":[{"award-number":["648131"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["847770"],"award-info":[{"award-number":["847770"]}]},{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z1710103"],"award-info":[{"award-number":["81Z1710103"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z0710114"],"award-info":[{"award-number":["81Z0710114"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Ministry of Research and Education"},{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","award":["101095480"],"award-info":[{"award-number":["101095480"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A budget impact analysis estimates the short-term difference between the cost of the current treatment strategy and a new treatment strategy, in this case to implement population screening for atrial fibrillation (AF). The aim of this study is to estimate the financial impact of implementing population-based AF-screening of 75-year-olds compared with the current setting of no screening from a healthcare payer perspective in eight European countries. The net budget impact of AF-screening was estimated in country-specific settings for Denmark, Germany, Ireland, Italy, Netherlands, Serbia, Spain, and Sweden. Country-specific parameters were used to allow for variations in healthcare systems and to reflect the healthcare sector in the country of interest. Similar results can be seen in all countries AF-screening incurs savings of stroke-related costs since AF treatment reduces the number of strokes. However, the increased number of detected AF and higher drug acquisition will increase the drug costs as well as the costs of physician- and control visits. The net budget impact per invited varied from \u20ac10 in Ireland to \u20ac122 in the Netherlands. The results showed the increased costs of implementing AF-screening were mainly driven by increased drug costs and screening costs. In conclusion, across Europe, though the initial cost of screening and more frequent use of oral anti-coagulants will increase the healthcare payers\u2019 costs, introducing population screening for AF will result in savings of stroke-related costs.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suae076","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T21:16:00Z","timestamp":1722546960000},"page":"iv19-iv32","source":"Crossref","is-referenced-by-count":7,"title":["The budget impact of implementing atrial fibrillation-screening in European countries"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7931-8941","authenticated-orcid":false,"given":"Michaela","family":"Eklund","sequence":"first","affiliation":[{"name":"Unit of Healthcare Analysis, Department of Medical and Health Sciences, Link\u00f6ping University , Link\u00f6ping , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0537-3319","authenticated-orcid":false,"given":"Lars","family":"Bernfort","sequence":"additional","affiliation":[{"name":"Unit of Healthcare Analysis, Department of Medical and Health Sciences, Link\u00f6ping University , Link\u00f6ping , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa","family":"Appelberg","sequence":"additional","affiliation":[{"name":"Unit of Healthcare Analysis, Department of Medical and Health Sciences, Link\u00f6ping University , Link\u00f6ping , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-6258","authenticated-orcid":false,"given":"Daniel","family":"Engler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Hamburg , Germany"},{"name":"DZHK (German Center for Cardiovascular Research) , Partner Site Hamburg\/Kiel\/Luebeck , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9509","authenticated-orcid":false,"given":"Renate B","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Hamburg , Germany"},{"name":"DZHK (German Center for Cardiovascular Research) , Partner Site Hamburg\/Kiel\/Luebeck , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Martinez","sequence":"additional","affiliation":[{"name":"Institute for Epidemiology, Statistics and Informatics GmbH , Frankfurt , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wallenhorst","sequence":"additional","affiliation":[{"name":"Institute for Epidemiology, Statistics and Informatics GmbH , Frankfurt , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, Italy University of Modena and Reggio Emilia, Policlinico di Modena , Modena , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M","family":"Buckley","sequence":"additional","affiliation":[{"name":"School of Public Health, University College Cork , Cork , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Z\u00f6ga","family":"Diederichsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital \u2013 Rigshospitalet , Inge Lehmanns Vej 7, 2100 Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Hastrup","family":"Svendsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital \u2013 Rigshospitalet , Inge Lehmanns Vej 7, 2100 Copenhagen , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Montaner","sequence":"additional","affiliation":[{"name":"Neurovascular Research Laboratory, Vall d\u2019Hebron Institute of Research (VHIR) Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"},{"name":"Institute de Biomedicine of Seville, IBiS\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/University of Seville"},{"name":"Department of Neurology, Hospital Universitario Virgen Macarena , Seville , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6902","authenticated-orcid":false,"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade , Belgrade , Serbia"},{"name":"Cardiology Clinic, University Clinical Centre of Serbia , Belgrade , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-4863","authenticated-orcid":false,"given":"Lars-\u00c5ke","family":"Levin","sequence":"additional","affiliation":[{"name":"Unit of Healthcare Analysis, Department of Medical and Health Sciences, Link\u00f6ping University , Link\u00f6ping , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4988-6346","authenticated-orcid":false,"given":"Johan","family":"Lyth","sequence":"additional","affiliation":[{"name":"Unit of Healthcare Analysis, Department of Medical and Health Sciences, Link\u00f6ping University , Link\u00f6ping , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"2024080110053911200_suae076-B1","author":"ESC Press Office","year":"2019"},{"key":"2024080110053911200_suae076-B2","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/CIRCULATIONAHA.117.028981","article-title":"Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE consortium (Biomarker for Cardiovascular Risk Assessment in Europe)","volume":"136","author":"Magnussen","year":"2017","journal-title":"Circulation"},{"key":"2024080110053911200_suae076-B3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/europace\/euz141","article-title":"Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI project","volume":"21","author":"Di Carlo","year":"2019","journal-title":"EP Europace"},{"key":"2024080110053911200_suae076-B4","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2024080110053911200_suae076-B5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Wang","year":"2004","journal-title":"Circulation"},{"key":"2024080110053911200_suae076-B6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/a-1541-3885","article-title":"Risk of ischemic stroke in asymptomatic atrial fibrillation incidentally detected in primary care compared with other clinical presentations","volume":"122","author":"Wallenhorst","year":"2022","journal-title":"Thromb Haemost"},{"key":"2024080110053911200_suae076-B7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40273-015-0263-1","article-title":"Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm","volume":"33","author":"Ali","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"2024080110053911200_suae076-B8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022638","article-title":"Ischemic stroke severity and mortality in patients with and without atrial fibrillation","volume":"11","author":"Vinding","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2024080110053911200_suae076-B9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024080110053911200_suae076-B10","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/STROKEAHA.120.029606","article-title":"Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years","volume":"51","author":"Wafa","year":"2020","journal-title":"Stroke"},{"key":"2024080110053911200_suae076-B11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2024080110053911200_suae076-B12","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-50482-7","volume-title":"Budget-Impact Analysis of Health Care Interventions","author":"Mauskopf","year":"2017"},{"key":"2024080110053911200_suae076-B13"},{"key":"2024080110053911200_suae076-B14","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2024080110053911200_suae076-B15","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211000213","article-title":"Budget impact analysis of anticoagulation clinics in patients with atrial fibrillation under chronic therapy with oral anticoagulants","volume":"12","author":"Uribe-Arango","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"2024080110053911200_suae076-B16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/13696998.2016.1182919","article-title":"Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: the case study of Japan","volume":"19","author":"Hori","year":"2016","journal-title":"J Med Econ"},{"key":"2024080110053911200_suae076-B17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/13696998.2021.1970954","article-title":"The IMPact of untReated nOn-valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model","volume":"24","author":"Sussman","year":"2021","journal-title":"J Med Econ"},{"key":"2024080110053911200_suae076-B18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2217\/cer-2019-0125","article-title":"Budget impacts associated with improving diagnosis and treatment of atrial fibrillation in high-risk stroke patients","volume":"9","author":"Orlowski","year":"2020","journal-title":"J Comp Eff Res"},{"key":"2024080110053911200_suae076-B19","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehab050","article-title":"Digital, risk-based screening for atrial fibrillation in the European community\u2014the AFFECT-EU project funded by the European union","volume":"42","author":"Engler","year":"2021","journal-title":"Eur Heart J"},{"key":"2024080110053911200_suae076-B20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/13696998.2021.1886108","article-title":"Budget impact analysis: can we afford the added value?","volume":"24","author":"Petrou","year":"2021","journal-title":"J Med Econ"},{"key":"2024080110053911200_suae076-B21"},{"key":"2024080110053911200_suae076-B22","author":"Vrangb\u00e6k"},{"key":"2024080110053911200_suae076-B23","author":"Bl\u00fcmel"},{"key":"2024080110053911200_suae076-B24","volume-title":"Germany: health system summary","author":"Bl\u00fcmel","year":"2022"},{"key":"2024080110053911200_suae076-B25","volume-title":"Ireland: Country Health Profile 2021","author":"European Observatory on Health Systems and Policies","year":"2021"},{"key":"2024080110053911200_suae076-B26"},{"issue":"4","key":"2024080110053911200_suae076-B27","first-page":"1","article-title":"Italy: health system review 2022","volume":"24","author":"Giulio de Belvis","year":"2022","journal-title":"Health Syst Transit"},{"key":"2024080110053911200_suae076-B28","article-title":"International Health Care System Profiles \u2013 Italy","author":"Donatini","year":"2020","journal-title":"The commonwealth fund, International Health Care System Profiles"},{"key":"2024080110053911200_suae076-B29","article-title":"International Health Care System Profiles \u2013 Netherlands.","author":"Tikkanen","journal-title":"The commonwealth fund"},{"key":"2024080110053911200_suae076-B30"},{"key":"2024080110053911200_suae076-B31","article-title":"Serbia: health system review 2019","volume":"21","author":"Bjegovic-Mikanovic","year":"2020","journal-title":"Health Syst Transit"},{"key":"2024080110053911200_suae076-B32"},{"key":"2024080110053911200_suae076-B33"},{"key":"2024080110053911200_suae076-B34","author":"Glenng\u00e5rd"},{"key":"2024080110053911200_suae076-B35","author":"OECD"},{"key":"2024080110053911200_suae076-B36"},{"key":"2024080110053911200_suae076-B37"},{"key":"2024080110053911200_suae076-B38"},{"key":"2024080110053911200_suae076-B39","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"2024080110053911200_suae076-B40","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-318882","article-title":"Refined atrial fibrillation screening and cost-effectiveness in the German population","author":"Schnabel","year":"2021","journal-title":"Heart"},{"key":"2024080110053911200_suae076-B41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/europace\/euu213","article-title":"A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke","volume":"17","author":"Levin","year":"2015","journal-title":"Europace"},{"key":"2024080110053911200_suae076-B42","first-page":"12","article-title":"Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in The Netherlands","volume":"20","author":"Jacobs","year":"2018","journal-title":"Europace"},{"key":"2024080110053911200_suae076-B43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/eurheartj\/ehac547","article-title":"Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study","volume":"44","author":"Lyth","year":"2023","journal-title":"Eur Heart J"},{"key":"2024080110053911200_suae076-B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21290","article-title":"Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis","volume":"21","author":"Welton","year":"2017","journal-title":"Health Technol Assess"},{"key":"2024080110053911200_suae076-B45","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeac022","article-title":"Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation","volume":"2","author":"Seelig","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2024080110053911200_suae076-B46","doi-asserted-by":"crossref","first-page":"20432","DOI":"10.1038\/srep20432","article-title":"Stroke prevention in atrial fibrillation and \u2018real world\u2019 adherence to guidelines in the Balkan region: the BALKAN-AF survey","volume":"6","author":"Potpara","year":"2016","journal-title":"Sci Rep"},{"key":"2024080110053911200_suae076-B47"},{"key":"2024080110053911200_suae076-B48","article-title":"Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs","volume":"115","author":"Hjemdahl","year":"2018","journal-title":"Lakartidningen"},{"key":"2024080110053911200_suae076-B49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3111\/13696998.2012.673525","article-title":"Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark","volume":"15","author":"Langkilde","year":"2012","journal-title":"J Med Econ"},{"key":"2024080110053911200_suae076-B50"},{"key":"2024080110053911200_suae076-B51"},{"key":"2024080110053911200_suae076-B52"},{"key":"2024080110053911200_suae076-B53"},{"key":"2024080110053911200_suae076-B54"},{"key":"2024080110053911200_suae076-B55"},{"key":"2024080110053911200_suae076-B56"},{"key":"2024080110053911200_suae076-B57"},{"key":"2024080110053911200_suae076-B58"},{"key":"2024080110053911200_suae076-B59"},{"key":"2024080110053911200_suae076-B60"},{"key":"2024080110053911200_suae076-B61"},{"key":"2024080110053911200_suae076-B62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s41669-019-00186-7","article-title":"Cost-effectiveness analysis of apixaban versus edoxaban in patients with atrial fibrillation for stroke prevention","volume":"4","author":"Oyag\u00fcez","year":"2020","journal-title":"PharmacoEcon Open"},{"key":"2024080110053911200_suae076-B63"},{"key":"2024080110053911200_suae076-B64","article-title":"Costing manual: Methodology of costing research and reference prices for economic evaluations in healthcare","author":"Hakkaart-van Roijen","journal-title":"National Health Care Institute"},{"key":"2024080110053911200_suae076-B65"},{"key":"2024080110053911200_suae076-B66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7175\/fe.v13i3.268","article-title":"Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy","volume":"13","author":"Mennini","year":"2012","journal-title":"Farmecon Health Econ Ther Pathways"},{"key":"2024080110053911200_suae076-B67","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.rec.2012.06.003","article-title":"Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain","volume":"65","author":"Gonz\u00e1lez-Juanatey","year":"2012","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2024080110053911200_suae076-B68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jval.2016.01.009","article-title":"Societal costs of first-incident ischemic stroke in patients with atrial fibrillation\u2014a Danish nationwide registry study","volume":"19","author":"Jakobsen","year":"2016","journal-title":"Value Health"},{"key":"2024080110053911200_suae076-B69","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jval.2016.07.007","article-title":"Cost-effectiveness of a national opportunistic screening program for atrial fibrillation in Ireland","volume":"19","author":"Moran","year":"2016","journal-title":"Value Health"},{"key":"2024080110053911200_suae076-B70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2377-12-137","article-title":"The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study","volume":"12","author":"Fattore","year":"2012","journal-title":"BMC Neurol"},{"key":"2024080110053911200_suae076-B71","doi-asserted-by":"crossref","first-page":"e0174861","DOI":"10.1371\/journal.pone.0174861","article-title":"Relationship between functional disability and costs one and two years post stroke","volume":"12","author":"Lekander","year":"2017","journal-title":"PLoS One"},{"key":"2024080110053911200_suae076-B72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10198-016-0799-9","article-title":"Economic impact of patients admitted to stroke units in Spain","volume":"18","author":"Alvarez-Sab\u00edn","year":"2017","journal-title":"Eur J Health Econ"},{"key":"2024080110053911200_suae076-B73","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.STR.0000217450.21310.90","article-title":"Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry","volume":"37","author":"Kolominsky-Rabas","year":"2006","journal-title":"Stroke"},{"key":"2024080110053911200_suae076-B74","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/ijs.12481","article-title":"Burden of stroke in Italy: an economic model highlights savings arising from reduced disability following thrombolysis","volume":"10","author":"Chiumente","year":"2015","journal-title":"Int J Stroke"},{"key":"2024080110053911200_suae076-B75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/1472-6963-12-315","article-title":"Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain","volume":"12","author":"Lopez-Bastida","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"2024080110053911200_suae076-B76","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.thromres.2014.05.027","article-title":"Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation","volume":"134","author":"Lanitis","year":"2014","journal-title":"Thromb Res"},{"key":"2024080110053911200_suae076-B77"},{"key":"2024080110053911200_suae076-B78"},{"key":"2024080110053911200_suae076-B79","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/joim.12114","article-title":"Atrial fibrillation prevalence revisited","volume":"274","author":"Friberg","year":"2013","journal-title":"J Intern Med"},{"key":"2024080110053911200_suae076-B80","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/CLEP.S53420","article-title":"Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data","volume":"475","author":"Johansson","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2024080110053911200_suae076-B81","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/heartjnl-2020-316624","article-title":"Prevalence and incidence rates of atrial fibrillation in Norway 2004\u20132014","volume":"107","author":"Kjerpeseth","year":"2021","journal-title":"Heart"},{"key":"2024080110053911200_suae076-B82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/europace\/eus333","article-title":"Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients","volume":"15","author":"Wilke","year":"2013","journal-title":"Europace"},{"key":"2024080110053911200_suae076-B83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.recesp.2013.07.015","article-title":"Prevalence of atrial fibrillation in Spain, OFRECE study results","volume":"67","author":"G\u00f3mez-Doblas","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2024080110053911200_suae076-B84","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"2024080110053911200_suae076-B85","doi-asserted-by":"crossref","first-page":"e1002903","DOI":"10.1371\/journal.pmed.1002903","article-title":"Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals","volume":"16","author":"Lowres","year":"2019","journal-title":"PLoS Med"},{"key":"2024080110053911200_suae076-B86","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/europace\/euv083","article-title":"Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording","volume":"17","author":"Aronsson","year":"2015","journal-title":"Europace"},{"issue":"2","key":"2024080110053911200_suae076-B87","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ehjqcco\/qcaa092","article-title":"The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above. A Markov modelled analysis","volume":"8","author":"Sciera","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/26\/Supplement_4\/iv19\/58711327\/suae076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/26\/Supplement_4\/iv19\/58711327\/suae076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T21:16:51Z","timestamp":1722547011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/26\/Supplement_4\/iv19\/7725451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":87,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2024,7,31]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suae076","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,7]]}}}